Total Payments
$135,587
2024 Payments
$47,061
Companies
37
Transactions
512
Medicare Patients
4,648
Medicare Billing
$636,892
Payment Breakdown by Category
Other$116,888 (86.2%)
Food & Beverage$9,275 (6.8%)
Travel$8,814 (6.5%)
Consulting$375.00 (0.3%)
Education$235.90 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $116,888 | 92 | 86.2% |
| Food and Beverage | $9,275 | 344 | 6.8% |
| Travel and Lodging | $8,814 | 64 | 6.5% |
| Consulting Fee | $375.00 | 1 | 0.3% |
| Education | $235.90 | 11 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $82,067 | 177 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24,113 | 51 | $0 (2024) |
| Lilly USA, LLC | $20,063 | 29 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $3,034 | 36 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,315 | 2 | $0 (2021) |
| Horizon Therapeutics plc | $651.52 | 29 | $0 (2023) |
| Amgen Inc. | $550.29 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $470.40 | 20 | $0 (2024) |
| Travere Therapeutics, Inc. | $326.16 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $317.33 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,061 | 142 | Boehringer Ingelheim Pharmaceuticals, Inc. ($23,497) |
| 2023 | $34,617 | 97 | AstraZeneca Pharmaceuticals LP ($33,125) |
| 2022 | $33,596 | 111 | AstraZeneca Pharmaceuticals LP ($32,455) |
| 2021 | $15,324 | 62 | AstraZeneca Pharmaceuticals LP ($13,881) |
| 2020 | $651.05 | 15 | Janssen Pharmaceuticals, Inc ($375.00) |
| 2019 | $778.46 | 33 | AstraZeneca Pharmaceuticals LP ($191.57) |
| 2018 | $501.44 | 22 | Abbott Laboratories ($169.07) |
| 2017 | $3,059 | 30 | Otsuka America Pharmaceutical, Inc. ($2,735) |
All Payment Transactions
512 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $740.00 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $56.28 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,480.00 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $745.00 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $67.00 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.37 | General |
| 11/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $4.85 | General |
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,225.00 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $144.72 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $44.22 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.83 | General |
| 11/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,480.00 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $745.00 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Nephrology | ||||||
| 11/05/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $935.00 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $740.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 940 | 1,451 | $288,245 | $107,700 |
| 2022 | 14 | 1,124 | 1,830 | $401,080 | $154,009 |
| 2021 | 18 | 1,175 | 1,975 | $456,439 | $193,971 |
| 2020 | 21 | 1,409 | 2,680 | $481,845 | $181,212 |
Total Patients
4,648
Total Services
7,936
Medicare Billing
$636,892
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 278 | 423 | $74,871 | $24,962 | 33.3% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 21 | 73 | $31,317 | $16,668 | 53.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 137 | 243 | $33,048 | $14,397 | 43.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 43 | 46 | $30,406 | $12,711 | 41.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 67 | 109 | $20,710 | $9,739 | 47.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 90 | 169 | $25,688 | $9,100 | 35.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 58 | $17,110 | $5,704 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $11,468 | $4,792 | 41.8% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 35 | 65 | $29,835 | $4,119 | 13.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $11,160 | $3,938 | 35.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 134 | 188 | $2,632 | $1,571 | 59.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 64 | 127 | $83,947 | $35,519 | 42.3% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 28 | 116 | $49,764 | $26,795 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 249 | 406 | $71,862 | $24,421 | 34.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 160 | 289 | $39,304 | $15,530 | 39.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 121 | 212 | $32,224 | $11,651 | 36.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 134 | $25,460 | $10,408 | 40.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 71 | 72 | $21,240 | $7,194 | 33.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 22 | 27 | $11,583 | $6,223 | 53.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $11,956 | $5,585 | 46.7% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 40 | 84 | $38,556 | $5,376 | 13.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $8,928 | $3,461 | 38.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 14 | $2,520 | $1,062 | 42.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 158 | 244 | $3,416 | $713.75 | 20.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 32 | 32 | $320.00 | $71.08 | 22.2% |
About Dr. Mark Purcell, DO
Dr. Mark Purcell, DO is a Internal Medicine healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639183544.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Purcell, DO has received a total of $135,587 in payments from pharmaceutical and medical device companies, with $47,061 received in 2024. These payments were reported across 512 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($116,888).
As a Medicare-enrolled provider, Purcell has provided services to 4,648 Medicare beneficiaries, totaling 7,936 services with total Medicare billing of $636,892. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Greenville, SC
- Active Since 07/28/2006
- Last Updated 03/02/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1639183544
Products in Payments
- FARXIGA (Drug) $79,159
- JARDIANCE (Drug) $44,177
- SAMSCA (Drug) $2,832
- LOKELMA (Drug) $2,522
- INVOKANA (Drug) $1,315
- KRYSTEXXA (Biological) $857.16
- Kerendia (Drug) $470.40
- Veltassa (Drug) $417.92
- ACTHAR (Biological) $319.65
- JYNARQUE (Drug) $202.28
- Renal - PD (Device) $194.48
- BENLYSTA (Biological) $180.53
- CardioMEMS HF System (Device) $169.07
- Auryxia (Drug) $168.53
- Fabhalta (Drug) $136.49
- Tavneos (Drug) $128.71
- Rayaldee (Drug) $111.27
- NXSTAGE SYSTEM ONE (Device) $99.17
- Velphoro (Drug) $86.98
- OPTIFLUX (Device) $80.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greenville
Stephen Dyar, Md, MD
Internal Medicine — Payments: $381,835
Internal Medicine $381,835
Dr. John Catanzaro, Md, MD
Internal Medicine — Payments: $331,996
Internal Medicine $331,996
Bhumika Patel, M.d, M.D
Internal Medicine — Payments: $208,547
Internal Medicine $208,547
Dr. Thomas Gallaher, M.d, M.D
Internal Medicine — Payments: $208,355
Internal Medicine $208,355
Bruce Gray, D.o, D.O
Internal Medicine — Payments: $166,102
Internal Medicine $166,102
Dr. Jesse Jorgensen, M.d, M.D
Internal Medicine — Payments: $134,042
Internal Medicine $134,042